AMY WANG: Open Payments
NPI 1720699655 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$619 in 28 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $422 · 2025 $619
Food & beverage: $619
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $167 |
| ABBVIE INC. | 4 | $95 |
| PFIZER INC. | 4 | $84 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Kowa Pharmaceuticals America, Inc. | 3 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $45 |
| Lilly USA, LLC | 2 | $33 |
| Amgen Inc. | 2 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
Products named: Ozempic, QULIPTA, ZORYVE, XIFAXAN, ELIQUIS, NURTEC ODT, AIRSUPRA, ZEPBOUND.
Industry payments across FL — which companies pay providers there.
